FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Zhanna Jumadilova

Research Profile

Chemicals & Drugs

Disorders

Geographic Areas

United States

Activities & Behaviors

Living Beings

Young Adult

Concepts & Ideas

Procedures

Physiology

Urination

Co-author Network

Publications

TOP 3
Jeffrey P Weiss; Diane L Martire; Martin Carlsson; Mary P Fitzgerald; Theodore M Johnson; Zhanna Jumadilova; Atul Malhotra
Efficacy and safety of flexible dose fesoterodine in men and women with overactive bladder symptoms including nocturnal urinary urgency.
Karin S Coyne; Gale Harding; Zhanna Jumadilova; Jeffrey P Weiss
Defining urinary urgency: patient descriptions of "gotta go".
Kenneth Getz; Zachary Hallinan; Zhanna Jumadilova; Lynne Pauer; Diane Simmons; Marc Wilenzick; Marla Jo Brickman; Briggs Morrison
Meeting the obligation to communicate clinical trial results to study volunteers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Zhanna Jumadilova (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jeffrey P Weiss; Diane L Martire; Martin Carlsson; Mary P Fitzgerald; Theodore M Johnson; Zhanna Jumadilova; Atul Malhotra
Efficacy and safety of flexible dose fesoterodine in men and women with overactive bladder symptoms including nocturnal urinary urgency.
The Journal of urology 2013;189(4):1396-401.
2012: Karin S Coyne; Gale Harding; Zhanna Jumadilova; Jeffrey P Weiss
Defining urinary urgency: patient descriptions of "gotta go".
Neurourology and urodynamics 2012;31(4):455-9.
2012: Kenneth Getz; Zachary Hallinan; Zhanna Jumadilova; Lynne Pauer; Diane Simmons; Marc Wilenzick; Marla Jo Brickman; Briggs Morrison
Meeting the obligation to communicate clinical trial results to study volunteers.
Expert review of clinical pharmacology 2012;5(2):149-56.
2011: Bimal Malhotra; Zhanna Jumadilova; Xiaoxi Li; Christine Alvey; Maurice Dickins; Gregory Duczynski; Kuan Gandelman
Effects of the moderate CYP3A4 inhibitor, fluconazole, on the pharmacokinetics of fesoterodine in healthy subjects.
British journal of clinical pharmacology 2011;72(2):263-9.
2010: Linda Brubaker; Kristina Fanning; Erica L Goldberg; Joshua S Benner; Jeffrey N Trocio; Tamara Bavendam; Zhanna Jumadilova
Predictors of discontinuing overactive bladder medications.
BJU international 2010;105(9):1283-90.
2010: Joshua S Benner; Michael B Nichol; Eric S Rovner; Zhanna Jumadilova; Jose Alvir; Mohamed Hussein; Kristina Fanning; Jeffrey N Trocio; Linda Brubaker
Patient-reported reasons for discontinuing overactive bladder medication.
BJU international 2010;105(9):1276-82.
2009: Rebecca G Rogers; Gloria Bachmann; Harriette Scarpero; Zhanna Jumadilova; Franklin Sun; Jon D Morrow; Zhonghong Guan; Tamara Bavendam
Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
Current medical research and opinion 2009;25(9):2159-65.
2009: Joshua S Benner; Russell Becker; Kristina Fanning; Zhanna Jumadilova; Tamara Bavendam; Linda Brubaker
Bother related to bladder control and health care seeking behavior in adults in the United States.
The Journal of urology 2009;181(6):2591-8.
2008: Rebecca Rogers; Gloria Bachmann; Zhanna Jumadilova; Franklin Sun; Jon D Morrow; Zhonghong Guan; Tamara Bavendam
Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women.
International urogynecology journal and pelvic floor dysfunction 2008;19(11):1551-7.
2008: Karin S Coyne; V Elinoff; D A Gordon; D Y Deng; M Brodsky; D B Glasser; Zhanna Jumadilova; M Carlsson
Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
International journal of clinical practice 2008;62(6):925-31.
2007: Karin S Coyne; Mary Kay Margolis; Zhanna Jumadilova; Tamara Bavendam; Elizabeth Mueller; Rebecca Rogers
Overactive bladder and women's sexual health: what is the impact?
The journal of sexual medicine 2007;4(3):656-66.
2007: Karin S Coyne; Louis S Matza; Christine Thompson; Zhanna Jumadilova; Tamara Bavendam
The responsiveness of the OAB-q among OAB patient subgroups.
Neurourology and urodynamics 2007;26(2):196-203.
2006: Zhanna Jumadilova; Sujata Varadharajan; Prafulla Girase; Daniel A Ollendorf
Retrospective evaluation of outcomes in patients with overactive bladder receiving tolterodine versus oxybutynin.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2006;63(23):2357-64.
2005: Andreas M Pleil; Karin S Coyne; Pat Ray Reese; Zhanna Jumadilova; Eric S Rovner; Con J Kelleher
The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2005;8 Suppl 1():S25-34.
2005: Eleanor M Perfetto; Prasun R Subedi; Zhanna Jumadilova
Treatment of overactive bladder: a model comparing extended-release formulations of tolterodine and oxybutynin.
The American journal of managed care 2005;11(4 Suppl):S150-7.
2005: Sujata Varadharajan; Zhanna Jumadilova; Prafulla Girase; Daniel A Ollendorf
Economic impact of extended-release tolterodine versus immediate- and extended-release oxybutynin among commercially insured persons with overactive bladder.
The American journal of managed care 2005;11(4 Suppl):S140-9.
2005: Nicole M Nitz; Zhanna Jumadilova; Theodore Darkow; Jennifer R Frytak; Tamara Bavendam
Medical costs after initiation of drug treatment for overactive bladder: effects of selection bias on cost estimates.
The American journal of managed care 2005;11(4 Suppl):S130-9.
2005: Fadia T. Shaya; Steven Blume; Anna Gu; Teresa Zyczynski; Zhanna Jumadilova
Persistence with overactive bladder pharmacotherapy in a Medicaid population.
The American journal of managed care 2005;11(4 Suppl):S121-9.
2005: Zhanna Jumadilova; Teresa Zyczynski; Barbara Paul; Siva Narayanan
Urinary incontinence in the nursing home: resident characteristics and prevalence of drug treatment.
The American journal of managed care 2005;11(4 Suppl):S112-20.